Reply: Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: The STAMP randomized trial.

Jeong, Hyehyun; Yoo, Changhoon

Jeong, Hyehyun; Yoo, Changhoon.

Affiliation

Jeong H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Hepatology ; 78(4): E74-E75, 2023 10 01.

Article in En | MEDLINE | ID: mdl-37459559

Subject(s)

Bile Duct Neoplasms; Cholangiocarcinoma; Humans; Capecitabine/therapeutic use; Cisplatin/therapeutic use; Gemcitabine; Deoxycytidine/therapeutic use; Cholangiocarcinoma/drug therapy; Bile Duct Neoplasms/drug therapy; Bile Ducts, Intrahepatic; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Chemotherapy, Adjuvant

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Type of study: Clinical_trials Limits: Humans Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google